On March 18, 2020 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, reported that it has rescheduled its fourth quarter and full year 2019 earnings conference call to Thursday, March 26, 2020, due to scheduling conflicts (Press release, Biolase Technology, MAR 18, 2020, View Source [SID1234555681]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIOLASE will host a conference call and webcast on Thursday, March 26, 2020 at 4:30 p.m. ET / 1:30 p.m. PT to discuss its operating results for the fourth quarter and full year ended December 31, 2019, and answer questions.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is 800-353-6461. For international participants outside the U.S./Canada, the dial-in number is 334-323-0501. For all callers, refer to the Conference ID 7830999. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investor Relations section of the BIOLASE website.